Pioglitazone as an Adjunct for Moderate to Severe Depressive Disorder

Related content

• Research Output

• Pioglitazone adjunctive therapy for moderate-to-severe major depressive disorder: Randomized double-blind placebo-controlled trial

  Research output: Contribution to journal › Article › peer-review